PhosPrints capabilities are improved by the laser bioprinting method.
PhosPrint has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in June 2022.
PhosPrint's investors include European Innovation Council.
PhosPrint is headquartered in Ayía Paraskeví, Greece.
PhosPrints capabilities are improved by the laser bioprinting method.
PhosPrint is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PhosPrint — Funding & Investors." VCBacked, June 15, 2022, https://www.vcbacked.co/company/phosprint. Accessed September 30, 2026.
VCBacked. (2022). PhosPrint — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/phosprint
{{cite web |title=PhosPrint — Funding & Investors |url=https://www.vcbacked.co/company/phosprint |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated